Moderna
Cambridge, US · Founded 2016 · 6,242 employees on LinkedIn · 7 known investors
Find your way into Moderna
2,226 people in our graph share verified history with the Moderna team — schools, employers, funds. One of them is your warm intro.
Niki Pezeshkiunlockedknows Lorence Kim · together at Goldman Sachs (overlapped)
knows the team · via Harvard University
×7knows the team · via Goldman Sachs
knows the team · via Boston College Law School
knows the team · via University of Pennsylvania School of Medicine
knows the team · via Nominal
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
Founders & leadership
Moderna was founded in 2016 by Robert Langer and Noubar Afeyan, Ph.D..
RL
Robert LangerCo-founder
NA
Noubar Afeyan, Ph.D.Co-founder and Chairman, Moderna; CEO, Flagship PioneeringGeneral Partner at Flagship Pioneering
LK
JR
James R. KasingerinGeneral Counsel and Corporate Secretary2014–2017Executive Officer at Moderna, an mRNA-based medicines platform company. Kasinger has held in-house and private practice legal roles in biotechnology and technology sectors, with expertise in corporate law, securities, M&A, venture capital, and governance matters.
SH
Stephen HogeinPresident
Board
SB
JM
John MendleinBoard director
NA
PH
Peter HuttBoard director
EN
Elizabeth NabelBoard director
HT
Henri TermeerBoard director
LB
Lee BabissBoard director
Investors · 7
Funding
SEC filings, press & company announcements$1B disclosed across 3 of 5 rounds · 2013–2026
- Undisclosed amountconvertible notesAug 2026Source ↗
▶$451.4MraisedAug 2016 · 72 investors · BiotechnologyRule 506(b)
▶$451.4MraisedAug 2016 · 72 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lorence KimExecutive Officer
- Stephane BancelExecutive Officer, Director
- Robert LangerDirector
- Peter HuttDirector
- John MendleinDirector
- James R. KasingerExecutive Officer
- Elizabeth NabelDirector
- Stephen HogeExecutive Officer
- Henri TermeerDirector
- Noubar AfeyanDirector
- Lee BabissDirector
- Offering amount
- $600M
- Amount sold
- $451.4M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$446.1MraisedJan 2015 · 43 investors · PharmaceuticalsRule 506(b)
▶$446.1MraisedJan 2015 · 43 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephane BancelExecutive Officer, Director
- Lorence KimExecutive Officer
- James KasingerExecutive Officer
- Noubar AfeyanDirector
- Lee BabissDirector
- Robert CarpenterDirector
- Theo Melas-KyriaziDirector
- Robert LangerDirector
- Peter HuttDirector
- John MendleinDirector
- Henri TermeerDirector
- Offering amount
- $502.2M
- Amount sold
- $446.1M
- First sale
- Dec 2014
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$135MraisedJan 2014 · 40 investors · PharmaceuticalsRule 506(b)
▶$135MraisedJan 2014 · 40 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Henri TermeerDirector
- Lee BabissDirector
- Theo Melas-KyriaziDirector
- Robert CarpenterDirector
- John MendleinDirector
- Robert LangerDirector
- Noubar AfeyanDirector
- Stephane BancelExecutive Officer, Director
- Peter HuttDirector
- Offering amount
- $135M
- Amount sold
- $135M
- First sale
- Nov 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
The Moderna mafia →6 people who came through Moderna went on to found or lead other companies.
Dave JohnsonAssociate Director, InformaticsFounded Dash BioNoubar AfeyanDirectorFounded ProFound Therapeutics +12Andrew FraleyHead of ChemistryFounded Korro Bio +1Roi RazSr. Director - Investor RelationsFounded ReBioTatiana NovobrantsevaChief Scientific Officer, Immuno-Oncology ResearchFounded Verseau TherapeuticsIgor FeldmanExecutive Director, Head of Clinical & Translational BioinformaticsFounded Verseau Therapeutics
Competitors · 2
by search overlapWorld Health Organization, 2025692 shared keywordsThe World Health Organization is a United Nations agency founded in 1948 that leads global health initiatives and emergency response across 194 member states. It works to expand universal health coverage, coordinate responses to health emergencies, and promote healthier lives across all life stages.
Walgreens624 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Companies competing with Moderna for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines | BioPharma Divebiopharmadive.com · Aug 2026
OCC urges Congress to boost federal pipeline safety grant funding in Oklahomajournalrecord.com · Jul 2026
Lyora Therapeutics Launches With Seed Funding to Propel Its Biologically Validated Pipeline of Genetic Medicines to Treat Inherited Retinal Diseases | The Manila Timesmanilatimes.net · Jul 2026
Erasca Raises $550M for RAS-Targeting Cancer Pipelineallsci.com · Jul 2026Frequently asked questions
- What does Moderna do?
- Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
- Who founded Moderna?
- Moderna was founded by Robert Langer, Noubar Afeyan, Ph.D. in 2016.
- Who are Moderna's investors?
- Moderna's investors include Aglae Ventures, Blackstone Life Sciences, Flagship Pioneering, FPV, Khosla Ventures, Premji Invest, RA Capital.
- How much funding has Moderna raised?
- Moderna has disclosed $1B raised across 3 of its 5 known rounds.
- Where is Moderna headquartered?
- Moderna is headquartered in Cambridge, US.